Leading Covid-19 vaccine developer AstraZeneca agreed on Saturday to buy Boston pharmaceutical firm Alexion for $39 billion.
Covid-19 vaccine developer AstraZeneca to buy rare disease firm Alexion for $39 billion
Home BREAKING NEWS Covid-19 vaccine developer AstraZeneca to buy rare disease firm Alexion for $39...
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.